Last reviewed · How we verify
Ondansetron orodispersible film twice — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Ondansetron orodispersible film twice (Ondansetron orodispersible film twice) — Chongqing University Cancer Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ondansetron orodispersible film twice TARGET | Ondansetron orodispersible film twice | Chongqing University Cancer Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ondansetron orodispersible film twice CI watch — RSS
- Ondansetron orodispersible film twice CI watch — Atom
- Ondansetron orodispersible film twice CI watch — JSON
- Ondansetron orodispersible film twice alone — RSS
Cite this brief
Drug Landscape (2026). Ondansetron orodispersible film twice — Competitive Intelligence Brief. https://druglandscape.com/ci/ondansetron-orodispersible-film-twice. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab